Biotech Earnings Checkup: CLDX, DNDN, OPX

... prostate cancer diagnostic test, 4Kscore. And the second late-stage trial for the company's experimental Vitamin D therapy Rayaldy completed patient enrollment recently. That said, Opko is still trading upwards of 9 to 10 times annual revenue, so ...

http://ift.tt/1hRoKDf